![World's first centre for recurrent head and neck cancer launched - Professor Christopher Nutting Oncology World's first centre for recurrent head and neck cancer launched - Professor Christopher Nutting Oncology](https://www.chrisnutting-oncology.co.uk/cms/wp-content/uploads/2022/01/royalmarsden_67975358223_0-500x333.jpeg)
World's first centre for recurrent head and neck cancer launched - Professor Christopher Nutting Oncology
![Clinical results, patient cases and future developments II: Head & neck cancer – Kevin Harrington on Vimeo Clinical results, patient cases and future developments II: Head & neck cancer – Kevin Harrington on Vimeo](https://i.vimeocdn.com/filter/overlay?src0=https%3A%2F%2Fi.vimeocdn.com%2Fvideo%2F721395685-103bfcddfe6c239bc7e0e55bebd0924d2cb62b4d6b9033060d1f15df72cdd23c-d_1280x720&src1=https%3A%2F%2Ff.vimeocdn.com%2Fimages_v6%2Fshare%2Fplay_icon_overlay.png)
Clinical results, patient cases and future developments II: Head & neck cancer – Kevin Harrington on Vimeo
![Randomised trial of pembrolizumab versus standard treatment in patients with recurrent or metastatic head and neck cancer - ecancer Randomised trial of pembrolizumab versus standard treatment in patients with recurrent or metastatic head and neck cancer - ecancer](https://cdn.ecancer.org/17873-m.jpg)
Randomised trial of pembrolizumab versus standard treatment in patients with recurrent or metastatic head and neck cancer - ecancer
![Kevin Harrington, The Original Shark from Shark Tank and Inventor of The Infomercial Joins the Advisory Board of USARAD including its SecondOpinions.com® Division Kevin Harrington, The Original Shark from Shark Tank and Inventor of The Infomercial Joins the Advisory Board of USARAD including its SecondOpinions.com® Division](http://ww1.prweb.com/prfiles/2021/01/11/17654673/Kevin%20Harrington%200159%20AAA%202.jpeg)